Galderma Reports Positive Results for Facial Volume Loss Tied to Medication-Driven Weight Loss
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.